课题基金 / 基金详情

Toward a rational and novel therapy for clostridium difficile infection

Toward a rational and novel therapy for clostridium difficile infection
寻找艰难梭菌感染的合理且新颖的疗法
批准号:
249356
负责人:
Li Yingfu
金额:
$27.1万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2011
资助国家:
加拿大
项目状态:
已结题
起止时间:
2011-10-01 至 2014-10-01

项目摘要

项目成果

Li Yingfu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
"Clostridium difficile (C. difficile) infection (CDI) is one of the most frequent causes of health care-associated infectious diseases in Canada and other industrialized countries, with a mortality rate of approximately 6%. A Canadian study has reported t
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of a saliva and aptamer based antigen test for variants of concerns of SARS-CoV-2
  • 批准号:
    448952
  • 项目类别:
    Operating Grants
  • 资助金额:
    $36.31万
  • 财政年份:
    2021
  • 负责人:
    Li Yingfu
  • 依托单位:
A rapid at-home test for SARS-CoV-2
  • 批准号:
    429210
  • 项目类别:
    Operating Grants
  • 资助金额:
    $95.73万
  • 财政年份:
    2020
  • 负责人:
    Li Yingfu
  • 依托单位:
Developing a strain-specific test for rapid diagnosis of Clostridium difficile
  • 批准号:
    349761
  • 项目类别:
    Operating Grants
  • 资助金额:
    $0.73万
  • 财政年份:
    2016
  • 负责人:
    Li Yingfu
  • 依托单位:
Paper-based diagnostic device for colorectal cancer detection
  • 批准号:
    360996
  • 项目类别:
    Operating Grants
  • 资助金额:
    $29.35万
  • 财政年份:
    2016
  • 负责人:
    Li Yingfu
  • 依托单位:
海外基金